Share This Page
Drug Price Trends for DIALYVITE SUPREME D TABLET
✉ Email this page to a colleague
Average Pharmacy Cost for DIALYVITE SUPREME D TABLET
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| DIALYVITE SUPREME D TABLET | 10542-0009-09 | 0.34793 | EACH | 2026-03-18 |
| DIALYVITE SUPREME D TABLET | 10542-0009-09 | 0.34793 | EACH | 2026-02-18 |
| DIALYVITE SUPREME D TABLET | 10542-0009-09 | 0.34790 | EACH | 2026-01-21 |
| DIALYVITE SUPREME D TABLET | 10542-0009-09 | 0.34772 | EACH | 2025-12-17 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Market Analysis and Price Projections for DIALYVITE SUPREME D TABLET
What is DIALYVITE SUPREME D TABLET?
DIALYVITE SUPREME D TABLET is a multivitamin supplement containing essential vitamins such as D3 (cholecalciferol), aimed at supporting patients with conditions like osteoporosis, vitamin D deficiency, or those requiring added nutritional support.
Key Composition:
- Vitamin D3: 1000 IU per tablet
- Other nutrients: vitamins A, C, E, K, and minerals (varies by formulation)
Indications:
Primarily prescribed for vitamin D deficiency, osteoporosis management, immune support, and general nutritional supplementation.
Market Overview
Global Perspective
The global vitamin and mineral supplement market is valued at approximately USD 138 billion in 2022, projected to grow at a CAGR of 7% through 2028.
Regional Trends
- North America: Dominates with about 40% market share, driven by aging populations and high supplement usage.
- Asia-Pacific: Fastest growth, CAGR exceeding 10%, driven by increasing health awareness and rising disposable income.
- Europe: Stable, with growth aligned to aging demographics and preventive health focus.
Key Stakeholders
- Pharmaceutical companies (Pfizer, Abbott, GSK)
- Dietary supplement manufacturers
- Distributors and pharmacies
- Healthcare providers
Regulatory Environment
- US: FDA's Over-the-Counter (OTC) regulations govern supplement labeling and safety.
- EU: EMA oversees health claims, with strict compliance required.
- India: Directorate General of Health Services (DGHS) regulation with recent updates easing some import/export restrictions.
Competitive Landscape
| Manufacturer | Product Examples | Market Share | Pricing Strategy |
|---|---|---|---|
| Pfizer | Centrum Silver, Calciferol | 25% | Premium pricing |
| GSK | Vitaxin, Ostepure | 20% | Mid-range |
| Local/national brands (India) | Dialyvite, Procef D/Aashirvaad | 10-15% | Economical options |
| Other players | Various generics/pharmaceuticals | Remaining | Competitive pricing |
Pricing Comparison (USD per strip of 30 tablets)
- Pfizer Centrum Silver D: $12.50
- GSK Vitaxin D3: $11.75
- Local brands (e.g., Dialyvite Supreme D): $4.50 - $6.00
The prices vary based on formulation, branding, and regional distribution channels.
Price Projections for DIALYVITE SUPREME D TABLET
Short-Term (Next 1-2 years)
- Expected retail price: around USD 4.50 - $6.00 per strip
- Pricing influenced by generic competition and manufacturing costs
- Regional variations: Higher in developed markets, lower in emerging markets
Medium-Term (3-5 years)
- Anticipated price decline of 8-12% driven by increased competition and generic market entry
- Potential bundling with other multivitamin therapies, segmenting premium from budget options
Long-Term (5+ years)
- Price stabilization around USD 3.50 - $5.50 per strip
- Market growth tied to increased awareness of vitamin D deficiency and aging population demands
Factors Impacting Pricing
- Regulatory changes introducing tighter controls or subsidy policies
- Raw material cost fluctuations, especially for vitamin D3
- Changes in patent or exclusivity status, affecting generic entry
- Distribution channel dynamics, especially e-commerce penetration
Regulatory and Patent Status
DIALYVITE SUPREME D is a generic product based on reference formulations, with no current patent protections preventing generic manufacturing in most markets. Manufacturer's investments in quality certification and licensing influence market entry and pricing.
Key Market Challenges
- Price sensitivity in developing markets
- Competition from low-cost generics
- Regulatory hurdles in some regions
- Loss of exclusivity leading to erosion of brand premiums
Key Takeaways
- The global growth of vitamin D supplements supports market expansion for DIALYVITE SUPREME D.
- Price compression is substantial in markets with intense generics competition.
- The product's positioning as a budget-friendly supplement in emerging markets aligns with projected price declines.
- Regional regulatory landscapes greatly influence product pricing and market accessibility.
- Market share is expected to shift toward low-cost, high-volume manufacturers in upcoming years.
FAQs
1. What are the primary factors influencing DIALYVITE SUPREME D’s market price?
Production costs, raw material prices, regulatory compliance, competition, and regional distribution channels.
2. How does the pricing of DIALYVITE SUPREME D compare with global competitors?
It is generally priced lower than premium brands like Pfizer’s Centrum but aligned with localized generics.
3. What is the projected market growth rate for vitamin D supplements?
Between 7-10% CAGR globally through 2028.
4. Are there patent restrictions affecting DIALYVITE SUPREME D?
No; it is a generic product and not under patent protection in most markets.
5. What are the main regional differences affecting the product’s pricing strategy?
Developed markets have higher prices and strong brand loyalty, while emerging markets favor lower-cost options with less regulatory complexity.
References
- Grand View Research (2023). Vitamin & Mineral Supplement Market Size, Share & Trends.
- Fortune Business Insights (2022). Vitamin D Market Analysis.
- US Food and Drug Administration (2023). Dietary Supplement Regulations.
- European Medicines Agency (2022). Regulatory Guidelines on Food Supplements.
- Statista (2023). Global Vitamin and Supplement Market Data.
More… ↓
